Malaria Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers
Conditions:   Uncomplicated Malaria;   Asymptomatic Condition;   Falciparum Malaria Interventions:   Drug: ZY19489 + Ferroquine (FQ);   Drug: Placebo Sponsor:   Zydus Lifesciences Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults
Condition:   Malaria Intervention:   Drug: Pvs230D1-EPA/Matrix-M Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers
Conditions:   Uncomplicated Malaria;   Asymptomatic Condition;   Falciparum Malaria Interventions:   Drug: ZY19489 + Ferroquine (FQ);   Drug: Placebo Sponsor:   Zydus Lifesciences Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults
Condition:   Malaria Intervention:   Drug: Pvs230D1-EPA/Matrix-M Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers
Conditions:   Uncomplicated Malaria;   Asymptomatic Condition;   Falciparum Malaria Interventions:   Drug: ZY19489 + Ferroquine (FQ);   Drug: Placebo Sponsor:   Zydus Lifesciences Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults
Condition:   Malaria Intervention:   Drug: Pvs230D1-EPA/Matrix-M Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials

Pan-Malaria Transmission-Blocking Vaccine AnAPN1
Condition:   Malaria Intervention:   Drug: Vaccine AnAPN1 Sponsors:   Centre de Recherche Médicale de Lambaréné;   Global Health Innovative Technology Fund Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials